Development of a Rift Valley fever real-time RT-PCR assay that can ...

W.C. Wilson et al. / Journal of Virological Methods 193 (2013) 426–431 431
Menon, C., Hamza, M., Rahim, I., Hafez, M., Jambavalikar, M., Arishi, H., Aqeel, A.,
2003. Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness
in humans. Clin. Infect. Dis. 36, 245–252.
Archer, B.N., Weyer, J., Paweska, J., Nkosi, D., Leman, P., Tint, K.S., Blumberg, L., 2011.
Outbreak of Rift Valley fever affecting veterinarians and farmers in South Africa,
2008. S. Afr. Med. J. 101, 263.
Bird, B.H., Bawiec, D.A., Ksiazek, T.G., Shoemaker, T.R., Nichol, S.T., 2007a. Highly
sensitive and broadly reactive quantitative reverse transcription-PCR assay
for high-throughput detection of Rift Valley fever virus. J. Clin. Microbiol. 45,
3506–3513.
Bird, B.H., Khristova, M.L., Rollin, P.E., Ksiazek, T.G., Nichol, S.T., 2007b. Complete
genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus
strains reveals widespread virus movement and low genetic diversity due to
recent common ancestry. J. Virol. 81, 2805–2816.
Bird, B.H., Albarino, C.G., Hartman, A.L., Erickson, B.R., Ksiazek, T.G., Nichol, S.T.,
2008. Rift Valley fever virus lacking the NSs and NSm genes is highly attenuated,
confers protective immunity from virulent virus challenge, and allows
for differential identification of infected and vaccinated animals. J. Virol. 82,
2681–2691.
Borio, L., Inglesby, T., Peters, C.J., Schmaljohn, A.L., Hughes, J.M., Jahrling, P.B., Ksiazek,
T., Johnson, K.M., Meyerhoff, A., O’Toole, T., Ascher, M.S., Bartlett, J., Breman, J.G.,
Eitzen Jr., E.M., Hamburg, M., Hauer, J., Henderson, D.A., Johnson, R.T., Kwik, G.,
Layton, M., Lillibridge, S., Nabel, G.J., Osterholm, M.T., Perl, T.M., Russell, P., Tonat,
K., 2002. Hemorrhagic fever viruses as biological weapons: medical and public
health management. J. Am. Med. Assoc. 287, 2391–2405.
Carroll, S.A., Reynes, J.M., Khristova, M.L., Andriamandimby, S.F., Rollin, P.E., Nichol,
S.T., 2011. Genetic evidence for Rift Valley fever outbreaks in Madagascar resulting
from virus introductions from the East African mainland rather than enzootic
maintenance. J. Virol. 85, 6162–6267.
Chevalier, V., Pepin, M., Plee, L., Lancelot, R., 2010. Rift Valley fever – a threat for
Europe? Euro Surveill. 15, 19506–19510.
Drolet, B.S., Weingartl, H.M., Jiang, J., Neufeld, J., Marszal, P., Lindsay, R., Miller, M.M.,
Czub, M., Wilson, W.C., 2012. Development and evaluation of one-step rRT-PCR
and immunohistochemical methods for detection of Rift Valley fever virus in
biosafety level 2 diagnostic laboratories. J. Virol. Methods 179, 373–382.
Drosten, C., Gottig, S., Schilling, S., Asper, M., Panning, M., Schmitz, H., Gunther, S.,
2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses,
Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus,
dengue virus, and yellow fever virus by real-time reverse transcription-PCR.
J. Clin. Microbiol. 40, 2323–2330.
Dungu, B., Louw, I., Lubisi, A., Hunter, P., von Teichman, B.F., Bouloy, M., 2010. Evaluation
of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
Vaccine 28, 4581–4587.
El Mamy, A.B., Baba, M.O., Barry, Y., Isselmou, K., Dia, M.L., El Kory, M.O., Diop, M., Lo,
M.M., Thiongane, Y., Bengoumi, M., Puech, L., Plee, L., Claes, F., de La Rocque, S.,
Doumbia, B., 2011. Unexpected Rift Valley fever outbreak, northern Mauritania.
Emerg. Infect. Dis. 17, 1894–1896.
EMPRES, 2005. Emergency Prevention System, Transboundry Animal Diseases.
Euler, M., Wang, Y., Nentwich, O., Piepenburg, O., Hufert, F.T., Weidmann, M., 2012.
Recombinase polymerase amplification assay for rapid detection of Rift Valley
fever virus. J. Clin. Virol. 54, 308–312.
Fukushi, S., Nakauchi, M., Mizutani, T., Saijo, M., Kurane, I., Morikawa, S., 2012.
Antigen-capture ELISA for the detection of Rift Valley fever virus nucleoprotein
using new monoclonal antibodies. J. Virol. Methods 180, 68–74.
Garcia, S., Crance, J.M., Billecocq, A., Peinnequin, A., Jouan, A., Bouloy, M., Garin, D.,
2001. Quantitative real-time PCR detection of Rift Valley fever virus and its application
to evaluation of antiviral compounds. J. Clin. Microbiol. 39, 4456–4461.
Gerdes, G.H., 2002. Rift valley fever. The Veterinary clinics of North America. Food
Anim. Pract. 18, 549–555.
Gerdes, G.H., 2004. Rift Valley fever. Rev. Sci. Tech. 23, 613–623.
Grobbelaar, A.A., Weyer, J., Leman, P.A., Kemp, A., Paweska, J.T., Swanepoel, R.,
2011. Molecular epidemiology of Rift Valley fever virus. Emerg. Infect. Dis. 17,
2270–2276.
Hartley, D.M., Rinderknecht, J.L., Nipp, T.L., Clarke, N.P., Snowder, G.D., 2011. Potential
effects of Rift Valley fever in the United States. Emerg. Infect. Dis. 17, e1.
Ikegami, T., Makino, S., 2009. Rift valley fever vaccines. Vaccine 27 (Suppl. 4),
D69–D72.
Jansen van Vuren, P., Paweska, J.T., 2009. Laboratory safe detection of nucleocapsid
protein of Rift Valley fever virus in human and animal specimens by a sandwich
ELISA. J. Virol. Methods 157, 15–24.
Le Roux, C.A., Kubo, T., Grobbelaar, A.A., van Vuren, P.J., Weyer, J., Nel, L.H.,
Swanepoel, R., Morita, K., Paweska, J.T., 2009. Development and evaluation of
a real-time reverse transcription-loop-mediated isothermal amplification assay
for rapid detection of Rift Valley fever virus in clinical specimens. J. Clin. Microbiol.
47, 645–651.
Meegan, J.M., Yedloutschnig, R.J., Peleg, B.A., Shy, J., Peters, C.J., Walker, J.S., Shope,
R.E., 1987. Enzyme-linked immunosorbent assay for detection of antibodies to
Rift Valley fever virus in ovine and bovine sera. Am. J. Vet. Res. 48, 1138–1141.
Morrill, J.C., Peters, C.J., 2011. Protection of MP-12-vaccinated rhesus macaques
against parenteral and aerosol challenge with virulent Rift Valley fever virus.
J. Infect. Dis. 204, 229–236.
Morvan, J., Saluzzo, J.F., Fontenille, D., Rollin, P.E., Coulanges, P., 1991. Rift Valley
fever on the east coast of Madagascar. Res. Virol. 142, 475–482.
Nguku, P.M., Sharif, S.K., Mutonga, D., Amwayi, S., Omolo, J., Mohammed, O., Farnon,
E.C., Gould, L.H., Lederman, E., Rao, C., Sang, R., Schnabel, D., Feikin, D.R., Hightower,
A., Njenga, M.K., Breiman, R.F., 2010. An investigation of a major outbreak
of Rift Valley fever in Kenya: 2006–2007. Am. J. Trop. Med. Hyg. 83, 05–13.
Paweska, J.T., Burt, F.J., Swanepoel, R., 2005a. Validation of IgG-sandwich and IgMcapture
ELISA for the detection of antibody to Rift Valley fever virus in humans.
J. Virol. Methods 124, 173–181.
Paweska, J.T., Mortimer, E., Leman, P.A., Swanepoel, R., 2005b. An inhibition enzymelinked
immunosorbent assay for the detection of antibody to Rift Valley fever
virus in humans, domestic and wild ruminants. J. Virol. Methods 127, 10–18.
Paweska, J.T., van Vuren, P.J., Kemp, A., Buss, P., Bengis, R.G., Gakuya, F., Breiman,
R.F., Njenga, M.K., Swanepoel, R., 2008. Recombinant nucleocapsid-based ELISA
for detection of IgG antibody to Rift Valley fever virus in African buffalo. Vet.
Microbiol. 127, 21–28.
Peyrefitte, C.N., Boubis, L., Coudrier, D., Bouloy, M., Grandadam, M., Tolou, H.J.,
Plumet, S., 2008. Real-time reverse-transcription loop-mediated isothermal
amplification for rapid detection of rift valley Fever virus. J. Clin. Microbiol. 46,
3653–3659.
Roehrig, J.T., Layton, M., Smith, P., Campbell, G.L., Nasci, R., Lanciotti, R.S., 2002. The
emergence of West Nile virus in North America: ecology, epidemiology, and
surveillance. Curr. Top. Microbiol. Immunol. 267, 223–240.
Rusnak, J.M., Gibbs, P., Boudreau, E., Clizbe, D.P., Pittman, P., 2011. Immunogenicity
and safety of an inactivated Rift Valley fever vaccine in a 19-year study. Vaccine
29, 3222–3229.
Schroeder, M.E., Bounpheng, M.A., Rodgers, S., Baker, R.J., Black, W., Naikare, H.,
Velayudhan, B., Sneed, L., Szonyi, B., Clavijo, A., 2012. Development and performance
evaluation of calf diarrhea pathogen nucleic acid purification and
detection workflow. J. Vet. Diagn. Invest. 24, 945–953.
Sidwell, R.W., Huffman, J.H., Barnard, D.L., Smee, D.F., Warren, R.P., Chirigos, M.A.,
Kende, M., Huggins, J., 1994. Antiviral and immunomodulating inhibitors of
experimentally-induced Punta Toro virus infections. Antiviral Res. 25, 105–122.
Smithburn, K.C., 1949. Rift Valley fever: the neurotropic adaptation of the virus and
experimental use of the modified virus as a vaccine. Br. J. Exp. Pathol. 30, 1–16.
von Teichman, B., Engelbrecht, A., Zulu, G., Dungu, B., Pardini, A., Bouloy, M., 2011.
Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
Vaccine 29, 5771–5777.
Weaver, S.C., Reisen, W.K., 2010. Present and future arboviral threats. Antiviral Res.
85, 328–345.
Williams, R., Ellis, C.E., Smith, S.J., Potgieter, C.A., Wallace, D., Mareledwane, V.E.,
Majiwa, P.A., 2011. Validation of an IgM antibody capture ELISA based on a
recombinant nucleoprotein for identification of domestic ruminants infected
with Rift Valley fever virus. J. Virol. Methods 177, 140–146.
Wilson, W.C., Hindson, B.J., O’Hearn, E.S., Hall, S., Tellgren-Roth, C., Torres, C.,
Naraghi-Arani, P., Mecham, J.O., Lenhoff, R.J., 2009a. A multiplex real-time
reverse transcription polymerase chain reaction assay for detection and differentiation
of Bluetongue virus and Epizootic hemorrhagic disease virus
serogroups. J. Vet. Diagn. Invest. 21, 760–770.
Wilson, W.C., O’Hearn, E.S., Tellgren-Roth, C., Stallknecht, D.E., Mead, D.G., Mecham,
J.O., 2009b. Detection of all eight serotypes of Epizootic hemorrhagic disease
virus by real-time reverse transcription polymerase chain reaction. J. Vet. Diagn.
Invest. 21, 220–225.
Wilson, W.C., Weingartl, H., Drolet, B.S., Davé, K., Harpster, M.H., Johnson, P.A., Faburay,
B., Ruder, M., Richt, J., McVey, D.S., 2013. Diagnostic approached for Rift
Valley Fever. Devel. Biol. (Basel) 135, 73–78.
Won, S., Ikegami, T., Peters, C.J., Makino, S., 2006. NSm and 78-kilodalton proteins
of Rift Valley fever virus are nonessential for viral replication in cell culture. J.
Virol. 80, 8274–8278.